Evaluating the cost-utility of ferric derisomaltose versus ferric carboxymaltose in patients with inflammatory bowel disease and iron deficiency anaemia in Norway.
Saved in:
| Title: | Evaluating the cost-utility of ferric derisomaltose versus ferric carboxymaltose in patients with inflammatory bowel disease and iron deficiency anaemia in Norway. |
|---|---|
| Authors: | Detlie TE; Department of Gastroenterology, Akershus University Hospital, Lørenskog, Norway., Karlsen LN; Department of Internal Medicine, Stavanger University Hospital, Stavanger, Norway., Jørgensen E; Oecona AS, Oslo, Norway., Nanu N; Covalence Research Ltd, Harpenden, UK., Pollock RF; Covalence Research Ltd, Harpenden, UK. |
| Source: | Journal of medical economics [J Med Econ] 2025 Dec; Vol. 28 (1), pp. 291-301. Date of Electronic Publication: 2025 Feb 17. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Taylor & Francis Country of Publication: England NLM ID: 9892255 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1941-837X (Electronic) Linking ISSN: 13696998 NLM ISO Abbreviation: J Med Econ Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1941-837X |
|---|---|
| DOI: | 10.1080/13696998.2024.2444833 |
